NeuBase Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NeuBase Therapeutics, Inc.
CIK #0001173281
EDGAR Form CIK 2011 - 2025
10-K [0001173281]
10-Q [0001173281]
3 [0001173281]
4 [0001173281]
5 [0001173281]
8-K [0001173281]
D [0001173281]
SC 13D [0001173281]
SC 13G [0001173281]
Form 13D/13G Filer Form 13D/13G Subject Filed
Symetryx Corp Neubase Therapeutics Inc [2023-08-31]
Titcomb Shawn Neubase Therapeutics Inc [2019-08-27]
Thadke Shivaji Neubase Therapeutics Inc [2019-07-22]
Stephan Dietrich A Neubase Therapeutics Inc [2019-07-22]
Carnegie Mellon University Neubase Therapeutics Inc [2019-07-22]
Kershner Trading Americas LLC Neubase Therapeutics Inc [2019-07-18]
Greenlight Capital Inc Neubase Therapeutics Inc [2019-07-16]
Slakter Jason Scott OHR Pharmaceutical Inc [2016-01-29]
Broadfin Capital LLC OHR Pharmaceutical Inc [2015-04-07]
Visium Asset Management LP OHR Pharmaceutical Inc [2014-07-11]
View All
Form 3/4/5 Subject 2011 - 2025
Shiff Aleta
Shiff Barry
Symetryx Corp
NeuBase Therapeutics, Inc.
Stephan Dietrich A
Branning Todd P.
Richman Eric I
Prendergast Franklyn G
McDougall Gerald J
Goldstein Dov A MD
Ende Eric J
Mann William Roland
Rojas-Caro Sandra
Motesharei Kianoush
Backenroth Samuel
Bradshaw Curt
Miralles Gines Diego
Lipizzaner LLC
Hirschman Orin
Almenoff June Sherie
Slakter Jason Scott
Riedhammer Thomas M
Ferguson Michael
Greenstein Ira A
Taraporewala Irach B.
Ingerman Avner
Terms | Privacy | Guide
tony@aum13f.com